Defence Therapeutics Inc.

What is Defence Therapeutics Inc. (DTCFF) stock price today?

As of Dec 16, 2025, 5:50 PM UTC, Defence Therapeutics Inc. (DTCFF) stock is trading at $0.60. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date DTCFF stock quotes for informed trading decisions.

What is Defence Therapeutics Inc.'s market capitalization?

Defence Therapeutics Inc. (DTCFF) has a market capitalization of approximately $32.8M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Defence Therapeutics Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the DTCFF stock price changes.

What is the 52-week range for Defence Therapeutics Inc. stock?

Defence Therapeutics Inc. (DTCFF) stock has traded in a 52-week range of $0.2732 — $1.16. The 52-week range shows the highest and lowest prices at which DTCFF traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Defence Therapeutics Inc. stock price to this range provides context for recent price action.

How much trading volume does Defence Therapeutics Inc. stock have?

Defence Therapeutics Inc. (DTCFF) stock recently traded approximately 3.5K shares. Trading volume indicates market liquidity and investor interest in DTCFF. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Defence Therapeutics Inc. stock.

Does Defence Therapeutics Inc. pay dividends to shareholders?

Yes, Defence Therapeutics Inc. (DTCFF) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Defence Therapeutics Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Defence Therapeutics Inc.'s intraday price range?

Today, Defence Therapeutics Inc. (DTCFF) stock has traded in a range of $0.5642 — $0.60. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring DTCFF's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Defence Therapeutics Inc. stock data?

AlphaPilot sources real-time DTCFF stock quotes, fundamental financial data, and historical price charts for Defence Therapeutics Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Defence Therapeutics Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of DTCFF stock performance.